The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-(anthracen-9-ylmethyl)-N4-(4-(methylamino)butyl)butane-1,4-diamine trihydrochloride ID: ALA2403112
PubChem CID: 25218005
Max Phase: Preclinical
Molecular Formula: C24H34ClN3
Molecular Weight: 363.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNCCCCNCCCCNCc1c2ccccc2cc2ccccc12.Cl
Standard InChI: InChI=1S/C24H33N3.ClH/c1-25-14-6-7-15-26-16-8-9-17-27-19-24-22-12-4-2-10-20(22)18-21-11-3-5-13-23(21)24;/h2-5,10-13,18,25-27H,6-9,14-17,19H2,1H3;1H
Standard InChI Key: NSJLXHSFKAVLSC-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
28.0166 -5.8045 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.6316 -2.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6305 -3.6148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0589 -2.7838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3434 -2.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0617 -3.6143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3444 -4.0254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3429 -4.8503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7738 -4.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7758 -4.8488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0568 -5.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0568 -6.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7751 -6.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4948 -6.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4913 -5.2598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4878 -3.6118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2027 -4.0234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9167 -3.6100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6316 -4.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3456 -3.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0606 -4.0198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7745 -3.6064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4895 -4.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2035 -3.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9184 -4.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6324 -3.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3473 -4.0142 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0613 -3.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 7 1 0
6 4 1 0
4 5 2 0
5 2 1 0
6 7 1 0
7 8 2 0
8 11 1 0
10 9 1 0
9 6 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
9 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.55Molecular Weight (Monoisotopic): 363.2674AlogP: 4.45#Rotatable Bonds: 12Polar Surface Area: 36.09Molecular Species: BASEHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.03CX LogP: 3.94CX LogD: -4.61Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.33Np Likeness Score: -0.14
References 1. Muth A, Kamel J, Kaur N, Shicora AC, Ayene IS, Gilmour SK, Phanstiel O.. (2013) Development of polyamine transport ligands with improved metabolic stability and selectivity against specific human cancers., 56 (14): [PMID:23841465 ] [10.1021/jm400496a ]